Neuroblastoma has been associated genetically with amplification of th
e MYCN gene and with alteration of the short arm of chromosome 1 (1p).
In pursuit of determining the spectrum of genetic loci damaged recurr
ently in neuroblastoma cells we have recently encountered two addition
al types of genomic abnormalities: i.) duplication of the MYCN gene on
chromosome 2p24; and ii) amplification of the gene MDM2. These altera
tions extend the spectrum of genetic lesions in neuroblastoma cells, a
lthough their incidence in primary tumor tissues has not been determin
ed as yet.